Logo-themed crystal deal toy recognizing the recapitalization of Texas-based home health provider Frontpoint. (22AKL052)
Logo-themed crystal deal toy recognizing the recapitalization of Texas-based home health provider Frontpoint. (22AKL052)
Custom deal tombstone, featuring a crystal desktop monitor and pills on a base, marking the acquisition of Paciv. The company specializes in process automotion for regulatory compliance in the biotech, pharmaceutical, and medical device sectors. (23AKL327)
Crystal deal tombstone commemorating the acquisition by Quest Diagnostics of Lifelabs, the Canadian laboratory testing company. (24AKL491)
Crystal deal tombstone, featuring a cutout of a human brain, marking a follow-on offering by NeuroOne Meidcal Technologies. The Minnesota-based company’s technology targets patients suffering from neurological disorders. (25AKL138)
Crystal financial tombstone marking the acquisition of Adapted Nutrition, which specializes in the keto supplements market. (21ALJ612)
Custom Lucite celebrating the approval by the U.S. Food and Drug Administration (FDA) of the drug Crenessity. Crenessity was developed by Neurocrine Biosciences to treat a rare congenital adrenal condition. (25ALJ020)
Custom crystal, incorporating a pharma vial design, celebrating the successful initial public offering on the Euronext Growth Oslo exchange of Oncoinvent. The Oslo-based company is focused on cancer treatments. (25LNL007)
Crystal deal tombstone, incorporating two logo cutouts, marking the acquisition of two Missouri-based manufacturers of surgical instruments. (22ALJ096)